The president of the European Commission said on Tuesday that, after speaking to a German biotech firm, she hopes a vaccine against the novel coronavirus strain will be available this year.
Brussels' top official Ursula von der Leyen has held talks with executives from CureVac, a company that has received an offer of 80 million euros (USD 88 million) in EU financial support for its research.
"They are working on a promising technology to develop a vaccine against the coronavirus," the former German defence minister said in a online video message shortly before she was to join talks with the 27 EU leaders.
"The European Union is providing them up to 80 million euros and I hope that with this support we can have a vaccine on the market, perhaps before autumn. This could save lives in Europe and in the rest of the world too."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app